Log in to save to my catalogue

Endocan, sepsis, pneumonia, and acute respiratory distress syndrome

Endocan, sepsis, pneumonia, and acute respiratory distress syndrome

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f91796b3801241bea562bbf6981a3f23

Endocan, sepsis, pneumonia, and acute respiratory distress syndrome

About this item

Full title

Endocan, sepsis, pneumonia, and acute respiratory distress syndrome

Publisher

England: BioMed Central Ltd

Journal title

Critical care (London, England), 2018-10, Vol.22 (1), p.280-280, Article 280

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Acute respiratory distress syndrome (ARDS) and hospital-acquired pneumonia (HAP) are major problems of public health in intensive care units (ICUs), occurring in 15% of critically ill patients. Among the factors explaining ARDS development, sepsis is known as a frequent cause. Sepsis, ARDS, and HAP increase morbidity, mortality, length of stay in t...

Alternative Titles

Full title

Endocan, sepsis, pneumonia, and acute respiratory distress syndrome

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_f91796b3801241bea562bbf6981a3f23

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f91796b3801241bea562bbf6981a3f23

Other Identifiers

ISSN

1364-8535

E-ISSN

1466-609X,1364-8535

DOI

10.1186/s13054-018-2222-7

How to access this item